| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c62054659e58b2ee956906e13bfeb20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1c28aa286da4fb3134c008c8489994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ece2b6beadeee5ecfe19b1fe06a74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0343e7362de12c545e4f502143be2a40 |
| publicationDate |
2019-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201919695-A |
| titleOfInvention |
Use of Cona monoclonal antibody (CANAKINUMAB) |
| abstract |
The present invention relates to canakinumab, which is used to reduce the risk of or prevent such recurrent cardiovascular (CV) events in patients who already suffer from myocardial infarction (MI) with increased hsCRP. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113491820-A |
| priorityDate |
2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |